🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective was to assess the effectiveness evaluated by the time to ...
Status
Completed
Location
Investigational Site Number 056003
Start Date
2009-04
Trial ID
NCT00883337
Treatments Being Tested
Phase IV, 3-armed, prospective, open-label, single-center, Israeli study, e...
Status
Unknown
Location
Sheba Medical Center
Start Date
2021-03-20
Trial ID
NCT05075499
Treatments Being Tested
Primary Objective: To describe the safety of teriflunomide in patients wit...
Status
Completed
Location
Investigational Site Number :024
Start Date
2019-03-27
Trial ID
NCT03856619
Treatments Being Tested
The primary objective of the study was to assess the effect of two doses of...
Status
Completed
Location
Sanofi-Aventis Investigational Site Number 840041
Start Date
2008-08
Trial ID
NCT00751881
Treatments Being Tested
Multiple sclerosis (MS) is a common cause of severe neurological disability...
Status
Completed
Location
CHU de Bordeaux
Start Date
2017-09-25
Trial ID
NCT03122652
Treatments Being Tested
Primary Objective: To assess efficacy of daily SAR442168 compared to a dai...
Status
Completed
Location
University of Alabama MS Center-Site Number:8400013
Start Date
2020-06-30
Trial ID
NCT04410978
Treatments Being Tested
Primary Objective To determine if colestipol hydrochloride tablets can acce...
Status
Terminated
Location
USF Carol and Frank Morsani Center for Advanced Healthcare
Start Date
2015-03
Trial ID
NCT02263547
Treatments Being Tested
The primary objective of this study was to determine the safety and efficac...
Status
Completed
Location
Canada
Start Date
2001-04
Trial ID
NCT01487096
Treatments Being Tested
Primary Objective: \- To determine the effect of severe renal impairment o...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2010-11
Trial ID
NCT01239459
Treatments Being Tested
Primary Objective: To measure the effect of Teriflunomide on lymphocytes s...
Status
Completed
Location
Investigational Site Number 056001
Start Date
2013-10
Trial ID
NCT01863888
Treatments Being Tested